Dr. Mehmet Oz Faces Tough Questions on Medicare Cuts During Senate Hearing
Dr. Oz, Trump’s nominee for CMS, faces scrutiny over Medicaid cuts and financial ties at his confirmation hearing before the Senate Finance Committee.
Dr. Oz Won't Commit to Protecting Medicaid
Rolling Stone
Overview
Dr. Mehmet Oz, nominated by Trump to lead the Centers for Medicare and Medicaid Services, faced criticism during his Senate confirmation hearing. He was scrutinized particularly over potential cuts to Medicare and Medicaid, failing to directly answer questions about opposing such cuts. Senate Democrats raised concerns over his financial ties to health companies and past comments suggesting privatization of Medicare. Oz defended his commitment to improving healthcare and emphasized transparency, but his vague responses led to skepticism about his intentions, as he prepares to oversee a significant portion of federal healthcare spending.
Content generated by AI—learn more or report issue.
Get both sides in 5 minutes with our daily newsletter.
Analysis
Analysis unavailable for this viewpoint.
Articles (8)
Center (1)
No highlight available for this article.
ABC News·4M·FAQ
Dr. Mehmet Oz is nominated to lead the Centers for Medicare and Medicaid Services (CMS). If confirmed, he would oversee nearly $1.5 trillion in federal spending on Medicare and Medicaid, which cover over 150 million Americans.
Senate Democrats expressed concerns over Dr. Oz's past embrace of pseudoscience, anti-abortion statements, and potential conflicts of interest due to his financial ties to healthcare companies.
Dr. Oz has agreed to resign from positions at several companies and divest from healthcare companies, including UnitedHealth Group, as part of an ethics agreement.
Dr. Oz could influence decisions on major changes to Medicare and Medicaid, such as proposals to expand coverage for certain drugs or reverse Biden administration expansions to the Affordable Care Act's insurance marketplace.
History
- 4M
4 articles